Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.)

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Siklos, Eugene Nelson Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
428.28
Quantity 40,301 +18.9%
Value US$3,881,378
Thomvest Asset Management Ltd. 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
491.73
Quantity 59,528 -15.2%
Value US$2,428,981
Wach, Timothy Steven Director of Issuer Non-Executive Director
Transaction date
Sale
Price
480.26
Quantity 52,103
Value US$1,431,220
Sartore, Patrick Senior Officer of Issuer Officer
Transaction date
Sale
Price
8.50
Quantity 79
Value US$672
Sartore, Patrick Senior Officer of Issuer Officer
Transaction date
Sale
Price
8.50
Quantity 76
Value US$646
Sartore, Patrick Senior Officer of Issuer Officer
Transaction date
Sale
Price
8.50
Quantity 162
Value US$1,377
Pritchard, Bruce Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Sale
Price
8.50
Quantity 967
Value US$8,220
Pritchard, Bruce Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Sale
Price
8.50
Quantity 379
Value US$3,222
BEST, SIMON GEOFFREY Director of Issuer Non-Executive Director
Transaction date
Sale
Price
8.50
Quantity 1,517
Value US$12,894
BEST, SIMON GEOFFREY Director of Issuer Non-Executive Director
Transaction date
Sale
Price
8.50
Quantity 630
Value US$5,355
Sartore, Patrick Senior Officer of Issuer Officer
Transaction date
Sale
Price
0.43
Quantity 600 -26.9%
Value US$258
Iskra, Marie Senior Officer of Issuer Officer
Transaction date
Sale
Price
0.47
Quantity 9
Value US$4
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2023-10-01 2023-09-26 B Purchase

Director of Issuer

Non-Executive Director
40,301 +18.9%
428.28
US$3,881,378
40,301 +18.9% 428.28 US$3,881,378
2023-09-27 2023-09-26 B Purchase

10% Security Holder of Issuer

Large shareholder
59,528 -15.2%
491.73
US$2,428,981
59,528 -15.2% 491.73 US$2,428,981
2023-09-26 2023-09-26 S Sale

Director of Issuer

Non-Executive Director
52,103
480.26
US$1,431,220
52,103 480.26 US$1,431,220
2023-09-26 2023-09-26 S Sale

Senior Officer of Issuer

Officer
79
8.50
US$672
79 8.50 US$672
2023-09-26 2023-09-26 S Sale

Senior Officer of Issuer

Officer
76
8.50
US$646
76 8.50 US$646
2023-09-26 2023-09-26 S Sale

Senior Officer of Issuer

Officer
162
8.50
US$1,377
162 8.50 US$1,377
2023-09-26 2023-09-26 S Sale

Director of Issuer, Senior Officer of Issuer

Executive Director
967
8.50
US$8,220
967 8.50 US$8,220
2023-09-26 2023-09-26 S Sale

Director of Issuer, Senior Officer of Issuer

Executive Director
379
8.50
US$3,222
379 8.50 US$3,222
2023-09-26 2023-09-26 S Sale

Director of Issuer

Non-Executive Director
1,517
8.50
US$12,894
1,517 8.50 US$12,894
2023-09-26 2023-09-26 S Sale

Director of Issuer

Non-Executive Director
630
8.50
US$5,355
630 8.50 US$5,355
2022-12-15 2022-12-12 S Sale

Senior Officer of Issuer

Officer
600 -26.9%
0.43
US$258
600 -26.9% 0.43 US$258
2022-09-28 2022-09-12 S Sale

Senior Officer of Issuer

Officer
9
0.47
US$4
9 0.47 US$4
Explore more

More insider trading research around Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.)